Legal Representation
Attorney
Stephen R. Barrese
USPTO Deadlines
Next Deadline
311 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20161101)
Due Date
November 01, 2026
Grace Period Ends
May 01, 2027
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 1, 2025 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Oct 25, 2023 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Oct 25, 2023 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Oct 25, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Apr 27, 2023 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Nov 1, 2021 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Mar 29, 2017 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
| Mar 20, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Nov 21, 2016 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| Nov 1, 2016 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 6, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 6, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 17, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 3, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 3, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 24, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 24, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 23, 2016 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Apr 6, 2016 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 6, 2016 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 6, 2016 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 6, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 6, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 30, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 20, 2016 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Jan 20, 2016 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Jan 20, 2016 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Jan 14, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 20, 2015 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Nov 17, 2015 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Nov 16, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 27, 2015 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Oct 19, 2015 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Oct 16, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 16, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations for treatment of immunologic disorders, for immunoregulation, for treatment of autoimmune diseases, for treatment of inflammatory diseases, for treatment of arthritis, for Anti-cancer agents, for treatment of cancer, for treatment of tumor, for treatment of central nervous system disorders and for treatment of metabolic diseases; Preparations for treatment of immunologic disorders; Preparations for immunoregulation; Preparations for treatment of autoimmune diseases; Preparations for treatment of inflammatory diseases; Preparations for treatment of arthritis; Anti-cancer agents; Preparations for treatment of cancer; Preparations for treatment of tumor; Preparations for diagnosis for medical purposes; Preparations for treatment of central nervous system disorders; Preparations for treatment of metabolic diseases; Biological tissue cultures for medical purposes
Class 042
Pharmaceutical research and development; Bacteriological research; Biological research; Biotechnology research; Biopharmaceutical research and development; Medical product testing; Research and development for new products for others; Material testing; Chemistry services, namely, chemistry consultation; Chemical research and analysis; Biotechnology consultation; Pharmaceutical development using animal cells; Scientific technology research relating to plant genetics; Laboratory equipment rental
Additional Information
Other
In the statement, Page 1, line 1, "LTD" should be deleted, and LTD. should be inserted.
Classification
International Classes
005
042